
Daido Life's sales activities target the SME market. Policies from the corporate market*1 accounted for approximately 95% of the company's new policy amount in fiscal 2015.
For fiscal 2015, Daido Life's new policy amount was up 6.2% year on year to ¥4,315.5 billion*2. This increase was mainly due to strong sales of mainstay term life insurance and disability income insurance (J-type product, a non-participating critical illness insurance, and T-type product, a non-participating disability income insurance), and the new nursing care products Shunyu Relief (non-participating nursing care income protection insurance) and Kaigo Relief (non-participating whole life nursing care insurance). The surrender and lapse amount was up 3.9% year on year, to ¥2,472.0 billion*2, but the policy amount in force also rose 2.7% year on year to ¥39,205.9 billion*2, marking a net increase for the fourth consecutive year.
MCEV amounted to ¥1,078.0 billion at March 31, 2016, a decrease of ¥228.7 billion. This was mainly due to a decline in domestic interest rates.
- *1 The total of collective policies for individual insurance and individual annuities sold through tie-up groups and group insurance policies.
- *2 The sum of the policy amount of individual insurance and individual annuities (death benefit and living protection amounts), together with the insured amount for critical illnesses for the J-type product (non-participating critical illness insurance), disability income protection for the T-type product (non-participating disability income insurance) and Kaigo Relief (non-participating whole life nursing care insurance).
Policy Amount in Force
New Policy Amount and Share of J-type Product, T-type Product, and Nursing Care Products (Shunyu Relief and Kaigo Relief)